ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

DAVI vs SRTS // RSI-14 & 200D SMA MOMENTUM

Davion Healthcare Plc (NASDAQ) VS. Sensus Healthcare Inc. (NASDAQ) • 15-METRIC TALLY: DAVI 0 — SRTS 2
▲ RSI-14 & 200D SMA MOMENTUM LEADER: SRTS
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (DAVI VS. SRTS) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC DAVI SRTS SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — 43.20% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) — -31.30% — TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — 0.73% — TIE /fcf-yield <GO>
Operating Margin — -37.50% — TIE /operating-margins <GO>
Net Profit Margin — -28.10% — TIE /net-margins <GO>
Revenue Growth (YoY) — -34.30% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 6.50 — TIE /balance-sheet <GO>
Piotroski F-Score Quality — 5/9 — TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum ACTIVE 18.0 39.6 -21.60 SRTS /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $42.0M $45.4M -$3.4M SRTS /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR DAVI REV SRTS REV DAVI GROSS % SRTS GROSS % DAVI FCF SRTS FCF
FY 2025 — $27.5M — 43.2% — $332.0K
FY 2024 — $41.8M — 58.4% — -$1.1M
FY 2023 — $24.4M — — — -$2.1M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
DAVI // BETA —
SRTS // BETA —